IVX Health is a leading provider of infusion and injection therapy for those with complex chronic conditions such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis and other conditions. The company, founded in 2012, focuses on providing high-quality, personalized care for patients. IVX Health centers, located in the United States, offer convenient and flexible scheduling, including evenings and weekends. Patients have the opportunity to relax in their own private suite, complete with high-speed Wi-Fi, a flat screen TV, and comfortable recliners with room for guests. The recent Series F investment of $100.00M on 21 September 2021 demonstrates strong support from multiple notable investors, including Health Velocity Capital, Nueterra Capital, Great Hill Partners, McKesson Ventures, and Linden Capital Partners. This substantial investment reflects the confidence of these investors in the potential of IVX Health and its contribution to the Health Care and Health and Wellness industries. IVX Health's commitment to offering specialized care in a comfortable and accessible environment positions it as an attractive prospect for future growth and impact in the healthcare sector.
No recent news or press coverage available for IVX Health.